Kathleen A. Rickard
CIK 1836883 · Chief Medical Officer · last filed 2025-10-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
1
Total Filings
38
Lifetime Open-Market Net
-$5.68M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Verona Pharma plc (VRNA) Delisted | Chief Medical Officer | 0 | $106.91 | $0 | -$5.68M | 31 | 2025-10-08 |
Recent Filings · Page 3 of 4
38 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-11-03 | Verona Pharma plc (VRNA) Delisted | Mixed | −231,888 | -$414.7K | EDGAR |
| 2023-10-24 | Verona Pharma plc (VRNA) Delisted | Grant (A) | +200,000 | $0 | EDGAR |
| 2023-08-07 | Verona Pharma plc (VRNA) Delisted | Sell (S) | −80,144 | -$202.6K | EDGAR |
| 2023-08-03 | — | Notice (144) | −3,594 | -$74.2K | EDGAR |
| 2023-08-03 | Verona Pharma plc (VRNA) Delisted | Sell (S) | −33,464 | -$88.5K | EDGAR |
| 2023-05-11 | Verona Pharma plc (VRNA) Delisted | Exer (M) | +15,000 | $0 | EDGAR |
| 2023-05-03 | — | Notice (144) | −3,594 | -$75.0K | EDGAR |
| 2023-05-03 | Verona Pharma plc (VRNA) Delisted | Sell (S) | −106,176 | -$275.7K | EDGAR |
| 2023-02-03 | Verona Pharma plc (VRNA) Delisted | Mixed | −13,712 | -$302.7K | EDGAR |
| 2022-11-03 | Verona Pharma plc (VRNA) Delisted | Mixed | −85,016 | -$137.1K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.